Medical specialists from France tagged as investigators in clinical trials studying Prostatic Hyperplasia

Total 50 results

Alexandre de la Taille, Pr.
Seen in:
- Créteil, CHU Henri Mondor
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Ambroise Salin, Dr.
Seen in:
- Quint-Fonsegrives, Clinique La Croix du Sud
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Benjamin Pradère, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Brannwel Tibi, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Camille Overs, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Caroline Thuillier, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Charles Ballereau, Dr
Seen in:
- Lille, Hôpital Privé La Louvière
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
- NCT04838769 (Principal Investigator)
Conditions:
Constance Michel, MD
Seen in:
- Paris, Groupe Hospitalier Paris Saint-Joseph
Trials:
- NCT04761224 (Principal Investigator)
Conditions:
- Prostatic Hypertrophy
Emmanuel Della Negra, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Eric Barret, Dr.
Seen in:
- Paris, Institut Mutualiste Montsouris
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Evanguelos Xylinas, Dr
Seen in:
- Paris, Hôpital Bichat
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
- NCT04838769 (Principal Investigator)
Conditions:
Florian Laclergerie, Dr.
Seen in:
- Toulouse, CHU de Toulouse
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Franck Bruyère, Pr
Seen in:
- Amiens, Amiens University Hospital
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
- NCT05415631 (Principal Investigator)
Conditions:
Gaëlle Fiard, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Gilles Karsenty, Pr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Grégoire Robert, Pr.
Seen in:
- Bordeaux, CHU de Bordeaux
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Hakim Fassi-Fehri, Dr.
Seen in:
- Lyon, Hospices Civils de Lyon
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Héloïse Ducousso, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Idir Ouzaid, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Ismaël Galliot, Dr.
Seen in:
- Rouen, Clinique Saint Hilaire
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Jean-Alexandre Long, Pr.
Seen in:
- Grenoble, CHU Grenoble
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Jean-Luc Descotes, Pr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Jean-Nicolas Cornu, Pr.
Seen in:
- Rouen, CHU de Rouen
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Jonathan Olivier, Dr.
Seen in:
- Lille, Centre Hospitalier Universitaire de Lille
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Luc Corbel, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Marc Fourmarier, Dr.
Seen in:
- Aix-en-Provence, Centre Hospitalier du Pays d'Aix
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Matthieu Durand, Dr
Seen in:
- Nice, CHU de Nice
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
- NCT04838769 (Principal Investigator)
Conditions:

Clinical Trials on Prostatic Hyperplasia

GlaxoSmithKline

Completed

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

Benign Prostatic Hyperplasia
St. Joseph's Healthcare Hamilton
Ontario Ministry of Health and Long Term Care

Completed

PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate (PVP)

Benign Prostatic Hyperplasia

Canada
Assiut University

Not yet recruiting

Outcomes of Water Vapor Thermal Therapy (REZUM) in Management of Symptomatic Patients With Benign Prostatic Enlargement

Benign Prostatic Hyperplasia
NeoTract, Inc.

Not yet recruiting

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up (RELIEF)

Benign Prostatic Hyperplasia
Assiut University

Not yet recruiting

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia
Second Affiliated Hospital, School of Medicine,...

Recruiting

Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume

Benign Prostatic Hyperplasia

China
Jewish General Hospital

Not yet recruiting

Middle Lobe Only Laser Vaporization or Total Prostate Vaporization of the Prostate, Prospective Cohort Study

Benign Prostatic Hyperplasia
Zenflow, Inc.

Recruiting

The Zenflow Spring System EU Safety and Performance Study (ZEST EU)

Benign Prostatic Hyperplasia

Australia, New Zealand
REMD Medical Technology
RenJi Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Sun Yat-Sen... and other collaborators

Completed

Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

China
Bioaraba Health Research Institute

Completed

Effectiveness of Smartconsent in Improving Understanding of Informed Consent (SMARTCONSENT)

Benign Prostatic Hyperplasia

Spain

Medical specialists from France tagged as investigators in clinical trials studying Prostatic Hyperplasia

Clinical Trials on Prostatic Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations